Global Antiandrogen Monotherapy Market Research Report 2016

September 2016 | 126 pages | ID: G7701C81EE4EN
QYResearch

Abstracts

Notes:

Production, means the output of Antiandrogen Monotherapy

Revenue, means the sales value of Antiandrogen Monotherapy

This report studies Antiandrogen Monotherapy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Pfizer Inc. (USA)
• Abbott Laboratories (USA)
• Genentech Inc. (USA)
• GlaxoSmithKline Plc (UK)
• Immunomedics, Inc. (USA)
• Indevus Pharmaceuticals Inc. (USA)
• Novartis AG (Switzerland)
• OSI Pharmaceuticals, Inc. (USA)
• Paladin Labs Inc. (Canada)
• ALZA Corporation (USA)
• Amgen Inc. (USA)
• AstraZeneca PLC (UK)
• Medimmune, LLC (USA)
• Bristol-Myers Squibb Company (USA)
• Cell Genesys Inc. (USA)
• Dendreon Corporation (USA)
• EUSA Pharma, (USA) Inc. (USA)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Progenics Pharmaceuticals, Inc. (USA)
• Sanofi-Aventis SA (France)
• Spectrum Pharmaceuticals, Inc. (USA)
• Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Antiandrogen Monotherapy in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Antiandrogen Monotherapy in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Antiandrogen Monotherapy Market Research Report 2016

1 ANTIANDROGEN MONOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Antiandrogen Monotherapy Segment by Type
  1.2.1 Global Production Market Share of Antiandrogen Monotherapy by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Antiandrogen Monotherapy Segment by Application
  1.3.1 Antiandrogen Monotherapy Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Antiandrogen Monotherapy Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Antiandrogen Monotherapy (2011-2021)

2 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET COMPETITION BY MANUFACTURERS

2.1 Global Antiandrogen Monotherapy Production and Share by Manufacturers (2015 and 2016)
2.2 Global Antiandrogen Monotherapy Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Antiandrogen Monotherapy Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antiandrogen Monotherapy Market Competitive Situation and Trends
  2.5.1 Antiandrogen Monotherapy Market Concentration Rate
  2.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ANTIANDROGEN MONOTHERAPY PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Antiandrogen Monotherapy Production and Market Share by Region (2011-2016)
3.2 Global Antiandrogen Monotherapy Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ANTIANDROGEN MONOTHERAPY SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Antiandrogen Monotherapy Consumption by Regions (2011-2016)
4.2 North America Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Antiandrogen Monotherapy Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ANTIANDROGEN MONOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Antiandrogen Monotherapy Production and Market Share by Type (2011-2016)
5.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)
5.3 Global Antiandrogen Monotherapy Price by Type (2011-2016)
5.4 Global Antiandrogen Monotherapy Production Growth by Type (2011-2016)

6 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY APPLICATION

6.1 Global Antiandrogen Monotherapy Consumption and Market Share by Application (2011-2016)
6.2 Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ANTIANDROGEN MONOTHERAPY MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer Inc. (USA)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Abbott Laboratories (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Genentech Inc. (USA)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline Plc (UK)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Immunomedics, Inc. (USA)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Indevus Pharmaceuticals Inc. (USA)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Novartis AG (Switzerland)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 OSI Pharmaceuticals, Inc. (USA)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Paladin Labs Inc. (Canada)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 ALZA Corporation (USA)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Antiandrogen Monotherapy Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 ALZA Corporation (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Amgen Inc. (USA)
7.12 AstraZeneca PLC (UK)
7.13 Medimmune, LLC (USA)
7.14 Bristol-Myers Squibb Company (USA)
7.15 Cell Genesys Inc. (USA)
7.16 Dendreon Corporation (USA)
7.17 EUSA Pharma, (USA) Inc. (USA)
7.18 F. Hoffmann-La Roche Ltd. (Switzerland)
7.19 Progenics Pharmaceuticals, Inc. (USA)
7.20 Sanofi-Aventis SA (France)
7.21 Spectrum Pharmaceuticals, Inc. (USA)
7.22 Takeda Pharmaceutical Company Limited (Japan)

8 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS

8.1 Antiandrogen Monotherapy Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antiandrogen Monotherapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2016-2021)

12.1 Global Antiandrogen Monotherapy Production, Revenue Forecast (2016-2021)
12.2 Global Antiandrogen Monotherapy Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Antiandrogen Monotherapy Production Forecast by Type (2016-2021)
12.4 Global Antiandrogen Monotherapy Consumption Forecast by Application (2016-2021)
12.5 Antiandrogen Monotherapy Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antiandrogen Monotherapy
Figure Global Production Market Share of Antiandrogen Monotherapy by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Antiandrogen Monotherapy Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Antiandrogen Monotherapy Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Antiandrogen Monotherapy Production of Key Manufacturers (2015 and 2016)
Table Global Antiandrogen Monotherapy Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Monotherapy Production Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Production Share by Manufacturers
Table Global Antiandrogen Monotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table Global Market Antiandrogen Monotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Antiandrogen Monotherapy Average Price of Key Manufacturers in 2015
Table Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Antiandrogen Monotherapy Product Type
Figure Antiandrogen Monotherapy Market Share of Top 3 Manufacturers
Figure Antiandrogen Monotherapy Market Share of Top 5 Manufacturers
Table Global Antiandrogen Monotherapy Production by Regions (2011-2016)
Figure Global Antiandrogen Monotherapy Production and Market Share by Regions (2011-2016)
Figure Global Antiandrogen Monotherapy Production Market Share by Regions (2011-2016)
Figure 2015 Global Antiandrogen Monotherapy Production Market Share by Regions
Table Global Antiandrogen Monotherapy Revenue by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Market Share by Regions (2011-2016)
Table 2015 Global Antiandrogen Monotherapy Revenue Market Share by Regions
Table Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Table China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Table India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Antiandrogen Monotherapy Consumption Market by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Consumption Market Share by Regions (2011-2016)
Figure Global Antiandrogen Monotherapy Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Antiandrogen Monotherapy Consumption Market Share by Regions
Table North America Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)
Table Europe Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)
Table China Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)
Table Japan Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)
Table India Antiandrogen Monotherapy Production, Consumption, Import & Export (2011-2016)
Table Global Antiandrogen Monotherapy Production by Type (2011-2016)
Table Global Antiandrogen Monotherapy Production Share by Type (2011-2016)
Figure Production Market Share of Antiandrogen Monotherapy by Type (2011-2016)
Figure 2015 Production Market Share of Antiandrogen Monotherapy by Type
Table Global Antiandrogen Monotherapy Revenue by Type (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Antiandrogen Monotherapy by Type (2011-2016)
Figure 2015 Revenue Market Share of Antiandrogen Monotherapy by Type
Table Global Antiandrogen Monotherapy Price by Type (2011-2016)
Figure Global Antiandrogen Monotherapy Production Growth by Type (2011-2016)
Table Global Antiandrogen Monotherapy Consumption by Application (2011-2016)
Table Global Antiandrogen Monotherapy Consumption Market Share by Application (2011-2016)
Figure Global Antiandrogen Monotherapy Consumption Market Share by Application in 2015
Table Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2011-2016)
Figure Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Antiandrogen Monotherapy Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG (Switzerland) Antiandrogen Monotherapy Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ALZA Corporation (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) Antiandrogen Monotherapy Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure Global Antiandrogen Monotherapy Production and Growth Rate Forecast (2016-2021)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2016-2021)
Table Global Antiandrogen Monotherapy Production Forecast by Regions (2016-2021)
Table Global Antiandrogen Monotherapy Consumption Forecast by Regions (2016-2021)
Table Global Antiandrogen Monotherapy Production Forecast by Type (2016-2021)
Table Global Antiandrogen Monotherapy Consumption Forecast by Application (2016-2021)